Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
10.1038/nature09855 · doi-reference
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
10.1093/eurheartj/ehr073 · doi-reference
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
10.1242/dmm.008409 · doi-reference
Modelling the long QT syndrome with induced pluripotent stem cells
10.1038/nature09747 · doi-reference
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells
10.1016/j.jacc.2012.02.066 · doi-reference
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation
10.1111/j.1582-4934.2011.01476.x · doi-reference
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia
10.1002/emmm.201100194 · doi-reference
Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations
10.1371/journal.pone.0044660 · doi-reference
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
10.1093/hmg/ddr424 · doi-reference
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
10.1016/j.stem.2012.10.010 · doi-reference
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
10.1038/nature11799 · doi-reference
Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy
10.1093/eurheartj/ehs226 · doi-reference
Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy
10.1126/scitranslmed.3008008 · doi-reference
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells
10.1161/circulationaha.112.116996 · doi-reference
Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip
10.1039/c1lc20557a · doi-reference
Microfluidic heart on a chip for higher throughput pharmacological studies
10.1039/c3lc50350j · doi-reference
High-throughput single-molecule optofluidic analysis
10.1038/nmeth.1569 · doi-reference
Developing optofluidic technology through the fusion of microfluidics and optics
10.1038/nature05060 · doi-reference
iPSC disease modeling
10.1126/science.1227682 · doi-reference
Functional vascular endothelium derived from human induced pluripotent stem cells
10.1016/j.stemcr.2013.06.007 · doi-reference
Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes
10.1073/pnas.1413481111 · doi-reference
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model
10.1093/toxsci/kft205 · doi-reference
Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression
10.1038/nbt.2435 · doi-reference
Target identification and mechanism of action in chemical biology and drug discovery
10.1038/nchembio.1199 · doi-reference
An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes
10.5966/sctm.2013-0105 · doi-reference
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
10.1038/nm.3545 · doi-reference
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
10.1126/scitranslmed.3003552 · doi-reference
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
10.1038/nature09005 · doi-reference
Patient-specific induced pluripotent stem-cell models for long-QT syndrome
10.1056/nejmoa0908679 · doi-reference
Disease-specific induced pluripotent stem cells
10.1016/j.cell.2008.07.041 · doi-reference
Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity
10.1161/circulationaha.113.007394 · doi-reference
Activation of innate immunity is required for efficient nuclear reprogramming
10.1016/j.cell.2012.09.034 · doi-reference
Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels
10.1073/pnas.1205526109 · doi-reference
Labor pains of new technology: direct cardiac reprogramming
10.1161/circresaha.112.271445 · doi-reference
Recent advances in direct cardiac reprogramming
10.1016/j.gde.2015.09.004 · doi-reference
Heart repair by reprogramming non-myocytes with cardiac transcription factors
10.1038/nature11139 · doi-reference
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
10.1038/nature11044 · doi-reference
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
10.1016/j.cell.2010.07.002 · doi-reference
“Transdifferentiation” of C6 glial cells in culture
10.1126/science.6102413 · doi-reference
Engineering patient-specific valves using stem cells generated from skin biopsy specimens
10.1016/j.athoracsur.2014.04.075 · doi-reference
